New Zealand markets closed


NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
221.11-3.18 (-1.42%)
At close: 04:00PM EST
221.11 -0.09 (-0.04%)
After hours: 04:11PM EST
Full screen
Trade prices are not sourced from all markets
Previous close224.29
Bid221.03 x 800
Ask221.38 x 800
Day's range217.14 - 223.30
52-week range170.36 - 248.30
Avg. volume450,277
Market cap22.116B
Beta (5Y monthly)0.63
PE ratio (TTM)80.40
EPS (TTM)2.75
Earnings date31 Jan 2022 - 04 Feb 2022
Forward dividend & yield1.72 (0.78%)
Ex-dividend date22 Nov 2021
1y target est258.00
  • GlobeNewswire

    STERIS to Host a Conference Call for Fiscal 2022 Third Quarter Financial Results on February 9, 2022

    DUBLIN, IRELAND, Jan. 25, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 third quarter financial results at 10:00 a.m. ET on February 9, 2022. The conference call can be heard live at or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter

  • Zacks

    Steris (STE) Earnings Expected to Grow: Should You Buy?

    Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Zacks

    STERIS (STE) to Report Q3 Earnings: What's in the Cards?

    The ongoing integration of Cantel Medical business and robust demand from medical device customers are expected to have contributed to STERIS' (STE) Q3 performance.